Introduction In recent years, advances in surgical techniques and systemic therapies have enabled a subset of metastatic colorectal cancer (mCRC) patients to attain no evidence of disease (NED) status following complete tumor resection or localized treatment. However, this does not guarantee eradication: approximately 60–70 % of these patients (as reported in the JCOG0603 and EORTC40983 studies) experience recurrence or metastasis within five years—a leading cause of mortalit

Introduction: Recent therapeutic strategies for the treatment of triple-negative breast cancer (TNBC) have shifted the focus from...

Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells.In APL, there is...